FDA Announces Recall of Blood Pressure Medication After Failed Lab Test

The U.S. Food and Drug Administration in White Oak, Md., on July 20, 2020. Sarah Silbiger/Getty Images

A blood pressure medication that is produced by Sun Pharmaceuticals is being voluntarily recalled, according to an “enforcement report” issued by the U.S. Food and Drug Administration (FDA) this week.

Sun Pharmaceuticals is voluntarily recalling diltiazem hydrochloride in a 360-milligram dosage form across the United States, the FDA report said. Diltiazem hydrochloride is used to treat chest pain, high blood pressure, and some heart rhythm disorders like atrial fibrillation or rapid heartbeats.